$CYCN Cyclerion Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Cyclerion Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Cyclerion Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Cyclerion Therapeutics, Inc. for free.
CIK Number: 0001755237
IRS Number: 831895370
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CYCN
Company Address: 301 BINNEY STREET CAMBRIDGE 02142
Phone number: (857) 327-8778
Cyclerion Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | CYCN | Cyclerion Therapeu ... | Isacson Ole | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
Jun 28 2021 | CYCN | Cyclerion Therapeu ... | Churchwell Kevin | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
Jun 28 2021 | CYCN | Cyclerion Therapeu ... | Mendelsohn Michael | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
Jun 28 2021 | CYCN | Cyclerion Therapeu ... | CONRADES GEORGE H | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
Jun 28 2021 | CYCN | Cyclerion Therapeu ... | DESOUZA ERROL B | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
Jun 28 2021 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
Jun 07 2021 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Buy | P | 3.12 | 3,322 | 10,365 | 24,957 | 21.6 K to 25 K (+15.35 %) |
Jun 07 2021 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Buy | P | 3.12 | 92,831 | 289,633 | 697,313 | 604.5 K to 697.3 K (+15.36 %) |
Jun 07 2021 | CYCN | Cyclerion Therapeu ... | Slate Path Capital LP | 10% Owner | Buy | P | 3.12 | 961,538 | 2,999,999 | 7,157,601 | 6.2 M to 7.2 M (+15.52 %) |
May 10 2021 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Buy | P | 2.43 | 302,000 | 733,860 | 1,224,528 | 922.5 K to 1.2 M (+32.74 %) |
May 06 2021 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Buy | P | 2.53 | 398,001 | 1,006,943 | 922,528 | 524.5 K to 922.5 K (+75.88 %) |
May 06 2021 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Buy | P | 2.29 | 300,000 | 687,000 | 524,527 | 224.5 K to 524.5 K (+133.61 %) |
Mar 01 2021 | CYCN | Cyclerion Therapeu ... | Wright Christopher I | Chief Medical Offic ... | Sell | S | 3.99 | 2,637 | 10,522 | 42,728 | 45.4 K to 42.7 K (-5.81 %) |
Dec 30 2020 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President and CSO | Sell | S | 3.01 | 20,107 | 60,522 | 251,648 | 271.8 K to 251.6 K (-7.40 %) |
Nov 12 2020 | CYCN | Cyclerion Therapeu ... | Busch Andreas | Chief Innovation Of ... | Buy | P | 2.53 | 125,000 | 316,250 | 254,704 | 129.7 K to 254.7 K (+96.37 %) |